Incruse Ellipta and Insulin degludec Subcutaneous
Determining the interaction of Incruse Ellipta and Insulin degludec Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: umeclidinium
Brand name: Incruse Ellipta
Synonyms: n.a.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Incruse Ellipta-Insulin detemir
- Incruse Ellipta-Insulin Detemir (Cartridges and Prefilled Syringes)
- Incruse Ellipta-Insulin Detemir (Vials)
- Incruse Ellipta-Insulin detemir Subcutaneous
- Incruse Ellipta-Insulin glargine
- Incruse Ellipta-Insulin Glargine (U-100) Cartridge Systems and Pens
- Insulin degludec Subcutaneous-Indacaterol
- Insulin degludec Subcutaneous-Indacaterol and Glycopyrrolate
- Insulin degludec Subcutaneous-Indacaterol and glycopyrrolate Inhalation
- Insulin degludec Subcutaneous-Indacaterol inhalation
- Insulin degludec Subcutaneous-Indacaterol Maleate
- Insulin degludec Subcutaneous-Indapamide